Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ataibeckley Inc (ATAI)

Ataibeckley Inc (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ataibeckley Inc PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN \tP 1183 NLD

www.ataibeckley.com Employees: 54 P: 49-89-2153-9035

Sector:

Medical

Description:

AtaiBeckley Inc. is a clinical-stage biopharmaceutical company developing mental health treatments. The company's pipeline of novel therapies includes BPL-003 for treatment-resistant depression, VLS-01 for TRD and EMP-01 for social anxiety disorder. AtaiBeckley Inc., formerly known as Atai Beckley N.V., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 1,322,015
Enterprise Value, $K 1,325,005
Shares Outstanding, K 363,191
Float, K 265,856
% Float 73.20%
Short Interest, K 13,330
Short Float 3.67%
Days to Cover 3.58
Short Volume Ratio 0.43
% of Insider Shareholders 26.80%
% of Institutional Shareholders 28.41%

Financials:

Annual Sales, $ 310 K
Annual Net Income, $ -149,270 K
Last Quarter Sales, $ 750 K
Last Quarter Net Income, $ -61,070 K
EBIT, $ -104,360 K
EBITDA, $ -103,890 K

Growth:

1-Year Return 163.70%
3-Year Return 115.08%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 11/12/25
Next Earnings Date 03/16/26
Earnings Per Share ttm -0.81
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year -75.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 06/08/17
Dividend Payable Date 06/15/17
Dividend Payout Ratio 0.00%

ATAI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -107.70%
Return-on-Assets % -78.65%
Profit Margin % -48,151.61%
Debt/Equity 0.00
Price/Sales 239.70
Price/Cash Flow N/A
Price/Book 5.47
Book Value/Share 0.67
Interest Coverage -46.57
60-Month Beta 1.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar